When you are looking for a partner who is dedicated to Phase I trials and early development, rely on Quotient Sciences. We accelerate your molecule from first-in-human (FIH) to proof of concept (POC), helping you make critical decisions earlier. Whatever clinical pharmacology study you require, you can expect a fully integrated program, from study design to data reporting.
Your dedicated early-phase project manager will provide you with a customized service and third-party management/oversight. We deliver full-service programs on time, within budget, and to the highest quality to meet your rigorous requirements and those of the regulatory agencies. For more information about Quotient Sciences Project Management, click here.
Clinical unit with a dedicated 14C ADME ward and laboratory
On-site pharmaceutical laboratories and GMP manufacturing
9,000 active healthy volunteers in our database
Over 650 Phase I clinical studies completed
144-bed clinical unit with dedicated FIH wards
On-site pharmacy, with clean rooms for aseptic products
19,000 active healthy volunteers in our database
Recruitment for special subject populations
What Our Clients Say
"Quotient have a very valuable experience in conducting radiolabeled studies with microtracer technique and are open to customer requests and advice."